Yes, alopecia areata is an autoimmune disease. The immune system mistakenly attacks hair follicles, causing hair to fall out in patches. It affects roughly 2% of people over a lifetime, most commonly appearing between the ages of 18 and 49.
How the Immune System Attacks Hair Follicles
Hair follicles normally enjoy a form of biological protection called “immune privilege,” meaning the immune system largely leaves them alone. In alopecia areata, that protection breaks down. Specific immune cells, particularly a type of white blood cell called CD8+ T cells, swarm the base of hair follicles and attack them as though they were foreign invaders. Under a microscope, affected follicles show a dense cluster of immune cells that researchers sometimes describe as a “swarm of bees.”
The chain of events starts when follicles begin displaying proteins on their surface that essentially flag them for immune attention. This triggers an inflammatory cascade involving several signaling pathways. The follicle loses its local immunosuppressive environment, and T cells move in. The follicles don’t get destroyed permanently in most cases. They shrink and stop producing visible hair, but they remain alive beneath the skin. This is why regrowth is possible, sometimes even without treatment.
What It Looks Like and How It Progresses
Most people first notice one or more smooth, round bald patches on the scalp. About 80% of cases start with a single patch. The skin in the bald area looks normal, with no scarring or rash, which helps distinguish it from other causes of hair loss.
Doctors can often diagnose alopecia areata by appearance alone. A closer look with a handheld magnifying device called a trichoscope reveals telltale signs: “exclamation mark” hairs (short broken hairs that are wider at the tip and tapered at the base), black dots where hairs have broken off at scalp level, and yellow dots from keratin buildup in empty follicles. A biopsy is rarely needed.
The condition has three main forms:
- Patchy alopecia areata: one or more coin-sized bald spots, the most common presentation
- Alopecia totalis: complete loss of all scalp hair
- Alopecia universalis: loss of hair everywhere on the body, including eyebrows, eyelashes, and body hair
Less than 10% of people progress to extensive hair loss, and fewer than 1% develop alopecia universalis.
Genetics and Who Gets It
Alopecia areata can develop at any age, but it most commonly shows up in young adults. A large UK study found the median age at diagnosis was 35, with over a quarter of cases diagnosed between ages 18 and 29. About 9% of cases appear in adolescents aged 12 to 17.
Genetics play a significant role. Many of the genes linked to the condition belong to the human leukocyte antigen (HLA) complex, a group of genes that helps the immune system distinguish the body’s own cells from foreign ones. Variations in these HLA genes appear to make the immune system more likely to misidentify hair follicles as threats. Researchers have also identified dozens of other associated genes involved in inflammation and immune regulation, including genes related to signaling proteins that coordinate immune responses. Having a close family member with the condition increases your risk, though many people who develop it have no family history at all.
Connection to Other Autoimmune Conditions
Because alopecia areata involves a fundamentally misdirected immune system, it tends to travel with other immune-related conditions. Up to 38% of people with alopecia areata also have atopic conditions like eczema, asthma, or hay fever. Thyroid disease (particularly Hashimoto’s thyroiditis) and vitiligo, a condition where the immune system attacks pigment-producing cells in the skin, are also more common in people with alopecia areata than in the general population. If you’re diagnosed with alopecia areata, your doctor may check your thyroid levels as a precaution.
Chances of Hair Growing Back
The good news is that hair follicles remain alive even during active disease, so regrowth is always possible. Many people with limited patchy hair loss experience spontaneous regrowth without any treatment, sometimes within months. The unpredictability of the condition is one of its most frustrating features: hair may grow back in one area while falling out in another, and episodes can recur after years of remission.
For people with more extensive hair loss (over 40% of the scalp), the outlook is less certain. One long-term study followed 50 patients with extensive disease over three years and found that about 24% experienced complete or near-complete regrowth during that window. The more hair you’ve lost and the longer it’s been gone, the lower the chances of full spontaneous recovery, though it still happens.
How It’s Treated
Treatment depends on how much hair has been lost. For small patches, doctors often use corticosteroid injections directly into the bald spots to calm the local immune response. Topical treatments applied to the scalp can also help stimulate regrowth in mild cases.
For severe alopecia areata, the treatment landscape changed dramatically in 2022 when the FDA approved the first oral medication specifically for the condition. This drug, baricitinib, works by blocking a set of signaling pathways called JAK-STAT that the immune system uses to coordinate its attack on hair follicles. A second oral medication, ritlecitinib, received FDA approval in 2023 for both adults and adolescents with severe disease. These JAK inhibitors represent a major shift because they target the specific immune mechanism driving the hair loss rather than broadly suppressing the immune system.
These medications work best while you’re taking them. Hair loss can return if treatment is stopped, which means many people need to use them long-term. They also carry potential side effects that your doctor will monitor through regular blood work. Not everyone responds to treatment, and the degree of regrowth varies from person to person. For some, the results are dramatic; for others, the response is partial or slow.